Trilaciclib Combined With Chemotherapy for Perioperative Treatment of Osteosarcoma

NCT06217003 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma

Interventions

DRUG: Trilaciclib

Sponsor

The First Affiliated Hospital of Xinxiang Medical College